Gender and the regulation of longevity: Implications for autoimmunity

Autoimmunity Reviews

Volumn 11, Issue 6-7, 2012, Pages

  Pan, Zhen ^a,b   Chang, Christopher ^a,b  

^a Division of Allergy Asthma and Immunology ^*  (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Aging; Autoimmunity; Gender; Immune response; Insulin IGF 1; Longevity; Mitochondria; Oxidative stress; P53; Reactive oxygen species; Sex chromosome; Target of Rapamycin; Telomere

Indexed keywords

8 OXYDEOXYGUANOSINE; CYTOCHROME C OXIDASE; DEOXYGUANOSINE DERIVATIVE; DNA; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; G PROTEIN COUPLED RECEPTOR 30; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HLA B8 ANTIGEN; HLA DR11 ANTIGEN; HLA DR3 ANTIGEN; HLA DR5 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAMMALIAN TARGET OF RAPAMYCIN; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PHYTOESTROGEN; PROTEIN BAD; PROTEIN P53; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN C; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; APOPTOSIS; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BONE DEVELOPMENT; BREAST CANCER; CELL AGING; CELLULAR IMMUNITY; CHOLESTEROL BLOOD LEVEL; CYTOKINE RELEASE; DIET RESTRICTION; DNA DAMAGE; DNA METHYLATION; DOWN REGULATION; ENVIRONMENTAL FACTOR; ENVIRONMENTAL STRESS; ENZYME ACTIVATION; ESTROGEN RESPONSIVE ELEMENT; GENDER; GENE EXPRESSION; GENE MUTATION; HISTONE MODIFICATION; HUMAN; HUMORAL IMMUNITY; IMMUNOGENETICS; INFLAMMATION; KUPFFER CELL; LIFESPAN; LIVER INJURY; LONGEVITY; LYMPHOCYTE PROLIFERATION; MITOCHONDRION; MULTIPLE SCLEROSIS; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; POSTMENOPAUSE; REVIEW; SEPSIS; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TELOMERE; TH1 CELL; TRANSCRIPTION REGULATION; X CHROMOSOME INACTIVATION;

AGING; AUTOIMMUNITY; DIET; FEMALE; GONADAL STEROID HORMONES; HUMANS; LONGEVITY; MALE; MITOCHONDRIA; OXIDATIVE STRESS; SEX FACTORS; SIGNAL TRANSDUCTION; TELOMERE;

EID: 84862820802     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.12.004     Document Type: Review

References (152)

1. World population prospects: the 2010 Revision 2010.
2. Lindsay M., Howden J.A.M. Age and Sex composition: 2010, 2010 Census Briefs 2010.
3. Abbott A. Ageing: growing old gracefully. Nature 2004, 428:116-118.
4. Nussinovitch U., Shoenfeld Y. The role of gender and organ specific autoimmunity. Autoimmun Rev 2011, doi:10.1016/j.autrev.2011.11.001 [Electronic publication ahead of print].
5. Tower J., Arbeitman M. The genetics of gender and life span. J Biol 2009, 8:38.
6. Troen B.R. The biology of aging. Mt Sinai J Med 2003, 70:3-22.
7. Franceschi C., Monti D., Sansoni P., Cossarizza A. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today 1995, 16:12-16.
8. Franceschi C., Bonafe M. Centenarians as a model for healthy aging. Biochem Soc Trans 2003, 31:457-461.
9. Lin K., Dorman J.B., Rodan A., Kenyon C. daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans. Science 1997, 278:1319-1322.
10. Lin Y.J., Seroude L., Benzer S. Extended life-span and stress resistance in the Drosophila mutant methuselah. Science 1998, 282:943-946.
11. Guarente L., Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature 2000, 408:255-262.
12. Arantes-Oliveira N., Berman J.R., Kenyon C. Healthy animals with extreme longevity. Science 2003, 302:611.
13. Bartke A., Chandrashekar V., Dominici F., Turyn D., Kinney B., Steger R., et al. Insulin-like growth factor 1 (IGF-1) and aging: controversies and new insights. Biogerontology 2003, 4:1-8.
14. Hsu A.L., Murphy C.T., Kenyon C. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 2003, 300:1142-1145.
15. Benhar M., Engelberg D., Levitzki A. ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep 2002, 3:420-425.
16. Vigneron A., Vousden K.H. p53, ROS and senescence in the control of aging. Aging (Albany NY) 2010, 2:471-474.
17. Barja G., Herrero A. Oxidative damage to mitochondrial DNA is inversely related to maximum life span in the heart and brain of mammals. FASEB J 2000, 14:312-318.
18. Bernard K.E., Parkes T.L., Merritt T.J. A model of oxidative stress management: moderation of carbohydrate metabolizing enzymes in SOD1-null Drosophila melanogaster. PLoS One 2011, 6:e24518.
19. Chance B., Sies H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979, 59:527-605.
20. Miquel J., Economos A.C., Fleming J., Johnson J.E. Mitochondrial role in cell aging. Exp Gerontol 1980, 15:575-591.
21. Sastre J., Pallardo F.V., Pla R., Pellin A., Juan G., O'Connor J.E., et al. Aging of the liver: age-associated mitochondrial damage in intact hepatocytes. Hepatology 1996, 24:1199-1205.
22. Borras C., Sastre J., Garcia-Sala D., Lloret A., Pallardo F.V., Vina J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med 2003, 34:546-552.
23. Vina J., Hems R., Krebs H.A. Maintenance of glutathione content is isolated hepatocyctes. Biochem J 1978, 170:627-630.
24. Sastre J., Pallardo F.V., Vina J. Mitochondrial oxidative stress plays a key role in aging and apoptosis. IUBMB Life 2000, 49:427-435.
25. Vina J., Borras C., Gambini J., Sastre J., Pallardo F.V. Why females live longer than males: control of longevity by sex hormones. Sci Aging Knowledge Environ 2005, 2005:pe17.
26. Bensaad K., Vousden K.H. p53: new roles in metabolism. Trends Cell Biol 2007, 17:286-291.
27. Rivera A., Maxwell S.A. The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway. J Biol Chem 2005, 280:29346-29354.
28. Feng Z., Lin M., Wu R. The regulation of aging and longevity: a new and complex role of p53. Genes Cancer 2011, 2:443-452.
29. Yoon K.A., Nakamura Y., Arakawa H. Identification of ALDH4 as a p53-inducible gene and its protective role in cellular stresses. J Hum Genet 2004, 49:134-140.
30. Cunningham M., Gilkeson G. Estrogen receptors in immunity and autoimmunity. Clin Rev Allergy Immunol 2011, 40:66-73.
31. Peeva E. Reproductive immunology: a focus on the role of female sex hormones and other gender-related factors. Clin Rev Allergy Immunol 2011, 40:1-7.
32. Walker S.E. Estrogen and autoimmune disease. Clin Rev Allergy Immunol 2011, 40:60-65.
33. Paternostro G. Longevity and testosterone. Nature 1994, 368:408.
34. Owens I.P. Ecology and evolution. Sex differences in mortality rate. Science 2002, 297:2008-2009.
35. Weidemann W., Hanke H. Cardiovascular effects of androgens. Cardiovasc Drug Rev 2002, 20:175-198.
36. Mendelsohn M.E., Karas R.H. The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999, 340:1801-1811.
37. Angele M.K., Frantz M.C., Chaudry I.H. Gender and sex hormones influence the response to trauma and sepsis: potential therapeutic approaches. Clinics (Sao Paulo) 2006, 61:479-488.
38. Klein S.L. The effects of hormones on sex differences in infection: from genes to behavior. Neurosci Biobehav Rev 2000, 24:627-638.
39. Roberts C.W., Walker W., Alexander J. Sex-associated hormones and immunity to protozoan parasites. Clin Microbiol Rev 2001, 14:476-488.
40. Schroder J., Kahlke V., Staubach K.H., Zabel P., Stuber F. Gender differences in human sepsis. Arch Surg 1998, 133:1200-1205.
41. Zellweger R., Wichmann M.W., Ayala A., Stein S., DeMaso C.M., Chaudry I.H. Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med 1997, 25:106-110.
42. Angele M.K., Schwacha M.G., Ayala A., Chaudry I.H. Effect of gender and sex hormones on immune responses following shock. Shock 2000, 14:81-90.
43. Li P., Allen H., Banerjee S., Franklin S., Herzog L., Johnston C., et al. Mice deficient in IL-1 beta-converting enzyme are defective in production of mature IL-1 beta and resistant to endotoxic shock. Cell 1995, 80:401-411.
44. Kahlke V., Angele M.K., Ayala A., Schwacha M.G., Cioffi W.G., Bland K.I., et al. Immune dysfunction following trauma-haemorrhage: influence of gender and age. Cytokine 2000, 12:69-77.
45. Wichmann M.W., Ayala A., Chaudry I.H. Male sex steroids are responsible for depressing macrophage immune function after trauma-hemorrhage. Am J Physiol 1997, 273:C1335-C1340.
46. Angele M.K., Knoferl M.W., Schwacha M.G., Ayala A., Cioffi W.G., Bland K.I., et al. Sex steroids regulate pro- and anti-inflammatory cytokine release by macrophages after trauma-hemorrhage. Am J Physiol 1999, 277:C35-C42.
47. Mizushima Y., Wang P., Jarrar D., Cioffi W.G., Bland K.I., Chaudry I.H. Estradiol administration after trauma-hemorrhage improves cardiovascular and hepatocellular functions in male animals. Ann Surg 2000, 232:673-679.
48. Czlonkowska A., Ciesielska A., Gromadzka G., Kurkowska-Jastrzebska I. Gender differences in neurological disease: role of estrogens and cytokines. Endocrine 2006, 29:243-256.
49. Raju R., Bland K.I., Chaudry I.H. Estrogen: a novel therapeutic adjunct for the treatment of trauma-hemorrhage-induced immunological alterations. Mol Med 2008, 14:213-221.
50. Chakrabarti S., Lekontseva O., Davidge S.T. Estrogen is a modulator of vascular inflammation. IUBMB Life 2008, 60:376-382.
51. Prossnitz E.R., Sklar L.A., Oprea T.I., Arterburn J.B. GPR30: a novel therapeutic target in estrogen-related disease. Trends Pharmacol Sci 2008, 29:116-123.
52. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 2000, 14:1649-1660.
53. Kanda N., Watanabe S. 17Beta-estradiol enhances the production of nerve growth factor in THP-1-derived macrophages or peripheral blood monocyte-derived macrophages. J Invest Dermatol 2003, 121:771-780.
54. Hsieh Y.C., Yu H.P., Frink M., Suzuki T., Choudhry M.A., Schwacha M.G., et al. G protein-coupled receptor 30-dependent protein kinase A pathway is critical in nongenomic effects of estrogen in attenuating liver injury after trauma-hemorrhage. Am J Pathol 2007, 170:1210-1218.
55. Chagin A.S., Savendahl L. GPR30 estrogen receptor expression in the growth plate declines as puberty progresses. J Clin Endocrinol Metab 2007, 92:4873-4877.
56. Brailoiu E., Dun S.L., Brailoiu G.C., Mizuo K., Sklar L.A., Oprea T.I., et al. Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. J Endocrinol 2007, 193:311-321.
57. Sakamoto H., Matsuda K., Hosokawa K., Nishi M., Morris J.F., Prossnitz E.R., et al. Expression of G protein-coupled receptor-30, a G protein-coupled membrane estrogen receptor, in oxytocin neurons of the rat paraventricular and supraoptic nuclei. Endocrinology 2007, 148:5842-5850.
58. Ortona E., Margutti P., Matarrese P., Franconi F., Malorni W. Redox state, cell death and autoimmune diseases: a gender perspective. Autoimmun Rev 2008, 7:579-584.
59. Candore G., Balistreri C.R., Colonna-Romano G., Lio D., Listi F., Vasto S., et al. Gender-related immune-inflammatory factors, age-related diseases, and longevity. Rejuvenation Res 2010, 13:292-297.
60. Straub R.H. The complex role of estrogens in inflammation. Endocr Rev 2007, 28:521-574.
61. Candore G., Balistreri C.R., Listi F., Grimaldi M.P., Vasto S., Colonna-Romano G., et al. Immunogenetics, gender, and longevity. Ann N Y Acad Sci 2006, 1089:516-537.
62. May R.C. Gender, immunity and the regulation of longevity. Bioessays 2007, 29:795-802.
63. Vina J., Borras C., Gambini J., Sastre J., Pallardo F.V. Why females live longer than males? Importance of the upregulation of longevity-associated genes by oestrogenic compounds. FEBS Lett 2005, 579:2541-2545.
64. Vina J., Sastre J., Pallardo F., Borras C. Mitochondrial theory of aging: importance to explain why females live longer than males. Antioxid Redox Signal 2003, 5:549-556.
65. Munro I.C., Harwood M., Hlywka J.J., Stephen A.M., Doull J., Flamm W.G., et al. Soy isoflavones: a safety review. Nutr Rev 2003, 61:1-33.
66. Vergani D., Choudhuri K., Bogdanos D.P., Mieli-Vergani G. Pathogenesis of autoimmune hepatitis. Clin Liver Dis 2002, 6:727-737.
67. Candore G., Lio D., Colonna Romano G., Caruso C. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. Autoimmun Rev 2002, 1:29-35.
68. Candore G., Modica M.A., Lio D., Colonna-Romano G., Listi F., Grimaldi M.P., et al. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: a genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype. Biomed Pharmacother 2003, 57:274-277.
69. Rea I.M., Middleton D. Is the phenotypic combination A1B8Cw7DR3 a marker for male longevity?. J Am Geriatr Soc 1994, 42:978-983.
70. Candore G., Mantovani V., Balistreri C.R., Lio D., Colonna-Romano G., Cerreta V., et al. Frequency of the HFE gene mutations in five Italian populations. Blood Cells Mol Dis 2002, 29:267-273.
71. Lio D., Balistreri C.R., Colonna-Romano G., Motta M., Franceschi C., Malaguarnera M., et al. Association between the MHC class I gene HFE polymorphisms and longevity: a study in Sicilian population. Genes Immun 2002, 3:20-24.
72. Pes G.M., Lio D., Carru C., Deiana L., Baggio G., Franceschi C., et al. Association between longevity and cytokine gene polymorphisms. A study in Sardinian centenarians. Aging Clin Exp Res 2004, 16:244-248.
73. Lio D., Scola L., Crivello A., Colonna-Romano G., Candore G., Bonafe M., et al. Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10-1082 promoter SNP and its interaction with TNF-alpha -308 promoter SNP. J Med Genet 2003, 40:296-299.
74. Boekholdt S.M., Agema W.R., Peters R.J., Zwinderman A.H., van der Wall E.E., Reitsma P.H., et al. Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation 2003, 107:2416-2421.
75. van Heemst D., Beekman M., Mooijaart S.P., Heijmans B.T., Brandt B.W., Zwaan B.J., et al. Reduced insulin/IGF-1 signalling and human longevity. Aging Cell 2005, 4:79-85.
76. Kenyon C. The plasticity of aging: insights from long-lived mutants. Cell 2005, 120:449-460.
77. Al-Regaiey K.A., Masternak M.M., Bonkowski M., Sun L., Bartke A. Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor i/insulin signaling and caloric restriction. Endocrinology 2005, 146:851-860.
78. Fontana L. The scientific basis of caloric restriction leading to longer life. Curr Opin Gastroenterol 2009, 25:144-150.
79. Bader A.G., Kang S., Zhao L., Vogt P.K. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 2005, 5:921-929.
80. Calnan D.R., Brunet A. The FoxO code. Oncogene 2008, 27:2276-2288.
81. van der Horst A., Burgering B.M. Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol 2007, 8:440-450.
82. Holzenberger M., Dupont J., Ducos B., Leneuve P., Geloen A., Even P.C., et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003, 421:182-187.
83. Blagosklonny M.V. Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition. Cell Cycle 2006, 5:2087-2102.
84. Shaw R.J., Bardeesy N., Manning B.D., Lopez L., Kosmatka M., DePinho R.A., et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 2004, 6:91-99.
85. Inoki K., Corradetti M.N., Guan K.L. Dysregulation of the TSC-mTOR pathway in human disease. Nat Genet 2005, 37:19-24.
86. Inoki K., Guan K.L. Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment. Hum Mol Genet 2009, 18:R94-R100.
87. Kaeberlein M., Powers R.W., Steffen K.K., Westman E.A., Hu D., Dang N., et al. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science 2005, 310:1193-1196.
88. Kapahi P., Zid B.M., Harper T., Koslover D., Sapin V., Benzer S. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr Biol 2004, 14:885-890.
89. Jia K., Chen D., Riddle D.L. The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span. Development 2004, 131:3897-3906.
90. Hansen M., Taubert S., Crawford D., Libina N., Lee S.J., Kenyon C. Lifespan extension by conditions that inhibit translation in Caenorhabditis elegans. Aging Cell 2007, 6:95-110.
91. Vellai T., Takacs-Vellai K., Zhang Y., Kovacs A.L., Orosz L., Muller F. Genetics: influence of TOR kinase on lifespan in C. elegans. Nature 2003, 426:620.
92. Salminen A., Kaarniranta K. Glycolysis links p53 function with NF-kappaB signaling: impact on cancer and aging process. J Cell Physiol 2010, 224:1-6.
93. Kriete A., Mayo K.L. Atypical pathways of NF-kappaB activation and aging. Exp Gerontol 2009, 44:250-255.
94. Burnell A.M., Houthoofd K., O'Hanlon K., Vanfleteren J.R. Alternate metabolism during the dauer stage of the nematode Caenorhabditis elegans. Exp Gerontol 2005, 40:850-856.
95. Bluher M., Kahn B.B., Kahn C.R. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 2003, 299:572-574.
96. Lucanic M., Held J.M., Vantipalli M.C., Klang I.M., Graham J.B., Gibson B.W., et al. N-acylethanolamine signalling mediates the effect of diet on lifespan in Caenorhabditis elegans. Nature 2011, 473:226-229.
97. Anisimov V.N., Berstein L.M., Egormin P.A., Piskunova T.S., Popovich I.G., Zabezhinski M.A., et al. Metformin slows down aging and extends life span of female SHR mice. Cell Cycle 2008, 7:2769-2773.
98. Apfeld J., O'Connor G., McDonagh T., DiStefano P.S., Curtis R. The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev 2004, 18:3004-3009.
99. Greer E.L., Dowlatshahi D., Banko M.R., Villen J., Hoang K., Blanchard D., et al. An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr Biol 2007, 17:1646-1656.
100. Greer E.L., Brunet A. Different dietary restriction regimens extend lifespan by both independent and overlapping genetic pathways in C. elegans. Aging Cell 2009, 8:113-127.
101. Pallottini V., Montanari L., Cavallini G., Bergamini E., Gori Z., Trentalance A. Mechanisms underlying the impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in aged rat liver. Mech Ageing Dev 2004, 125:633-639.
102. Kaeberlein M., Powers R.W. Sir2 and calorie restriction in yeast: a skeptical perspective. Ageing Res Rev 2007, 6:128-140.
103. Berdichevsky A., Viswanathan M., Horvitz H.R., Guarente L. C. elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span. Cell 2006, 125:1165-1177.
104. Kenyon C.J. The genetics of ageing. Nature 2010, 464:504-512.
105. Vousden K.H., Prives C. Blinded by the light: the growing complexity of p53. Cell 2009, 137:413-431.
106. Levine A.J., Oren M. The first 30years of p53: growing ever more complex. Nat Rev Cancer 2009, 9:749-758.
107. Jin S., Martinek S., Joo W.S., Wortman J.R., Mirkovic N., Sali A., et al. Identification and characterization of a p53 homologue in Drosophila melanogaster. Proc Natl Acad Sci USA 2000, 97:7301-7306.
108. Soussi T., Caron de Fromentel C., Mechali M., May P., Kress M. Cloning and characterization of a cDNA from Xenopus laevis coding for a protein homologous to human and murine p53. Oncogene 1987, 1:71-78.
109. Shinomiya N. Analysis of the immunological pathogenesis of the seronegative autoimmune diseases. Nihon Rinsho Meneki Gakkai Kaishi 2002, 25:302-309.
110. Paleev F.N., Kotova A.A., Suchkov S.V., Paleev N.R. Autoimmune myocarditis: current aspects of immune pathogenesis. Vestn Ross Akad Med Nauk 2002, 52-56.
111. Waskar M., Landis G.N., Shen J., Curtis C., Tozer K., Abdueva D., et al. Drosophila melanogaster p53 has developmental stage-specific and sex-specific effects on adult life span indicative of sexual antagonistic pleiotropy. Aging (Albany NY) 2009, 1:903-936.
112. Maier B., Gluba W., Bernier B., Turner T., Mohammad K., Guise T., et al. Modulation of mammalian life span by the short isoform of p53. Genes Dev 2004, 18:306-319.
113. Mendrysa S.M., O'Leary K.A., McElwee M.K., Michalowski J., Eisenman R.N., Powell D.A., et al. Tumor suppression and normal aging in mice with constitutively high p53 activity. Genes Dev 2006, 20:16-21.
114. Caspi R.R. Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis. Int Rev Immunol 2002, 21:197-208.
115. Marciniak R., Guarente L. Human genetics. Testing telomerase. Nature 2001, 413:370-371. 3.
116. Bekaert S., De Meyer T., Van Oostveldt P. Telomere attrition as ageing biomarker. Anticancer Res 2005, 25:3011-3021.
117. Cawthon R.M., Smith K.R., O'Brien E., Sivatchenko A., Kerber R.A. Association between telomere length in blood and mortality in people aged 60years or older. Lancet 2003, 361:393-395.
118. Okuda K., Bardeguez A., Gardner J.P., Rodriguez P., Ganesh V., Kimura M., et al. Telomere length in the newborn. Pediatr Res 2002, 52:377-381.
119. Samani N.J., Boultby R., Butler R., Thompson J.R., Goodall A.H. Telomere shortening in atherosclerosis. Lancet 2001, 358:472-473.
120. von Zglinicki T., Serra V., Lorenz M., Saretzki G., Lenzen-Grossimlighaus R., Gessner R., et al. Short telomeres in patients with vascular dementia: an indicator of low antioxidative capacity and a possible risk factor?. Lab Invest 2000, 80:1739-1747.
121. Rolyan H., Scheffold A., Heinrich A., Begus-Nahrmann Y., Langkopf B.H., Holter S.M., et al. Telomere shortening reduces Alzheimer's disease amyloid pathology in mice. Brain 2011, 134:2044-2056.
122. Xin H., Liu D., Songyang Z. The telosome/shelterin complex and its functions. Genome Biol 2008, 9:232.
123. Burkle A. PARP-1: a regulator of genomic stability linked with mammalian longevity. Chembiochem 2001, 2:725-728.
124. Beneke S., Burkle A. Poly(ADP-ribosyl)ation in mammalian ageing. Nucleic Acids Res 2007, 35:7456-7465.
125. Burkle A., Diefenbach J., Brabeck C., Beneke S. Ageing and PARP. Pharmacol Res 2005, 52:93-99.
126. Masoro E.J. Caloric restriction and aging: an update. Exp Gerontol 2000, 35:299-305.
127. Honjoh S., Yamamoto T., Uno M., Nishida E. Signalling through RHEB-1 mediates intermittent fasting-induced longevity in C. elegans. Nature 2009, 457:726-730.
128. Hands S.L., Proud C.G., Wyttenbach A. mTOR's role in ageing: protein synthesis or autophagy?. Aging (Albany NY) 2009, 1:586-597.
129. Blagosklonny M.V. Linking calorie restriction to longevity through sirtuins and autophagy: any role for TOR. Cell Death Dis 2010, 1:e12.
130. Tissenbaum H.A., Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 2001, 410:227-230.
131. Medvedik O., Lamming D.W., Kim K.D., Sinclair D.A. MSN2 and MSN4 link calorie restriction and TOR to sirtuin-mediated lifespan extension in Saccharomyces cerevisiae. PLoS Biol 2007, 5:e261.
132. Selman C., Tullet J.M., Wieser D., Irvine E., Lingard S.J., Choudhury A.I., et al. Ribosomal protein S6 kinase 1 signaling regulates mammalian life span. Science 2009, 326:140-144.
133. Deelen J., Uh H.W., Monajemi R., van Heemst D., Thijssen P.E., Bohringer S., et al. Gene set analysis of GWAS data for human longevity highlights the relevance of the insulin/IGF-1 signaling and telomere maintenance pathways. Age (Dordr) 2011, doi:10.1007/s11357-011-9340-3 [Electronic publication ahead of print].
134. Weckerle C.E., Niewold T.B. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clin Rev Allergy Immunol 2011, 40:42-49.
135. Brooks W.H. X chromosome inactivation and autoimmunity. Clin Rev Allergy Immunol 2010, 39:20-29.
136. Christensen K., Kristiansen M., Hagen-Larsen H., Skytthe A., Bathum L., Jeune B., et al. X-linked genetic factors regulate hematopoietic stem-cell kinetics in females. Blood 2000, 95:2449-2451.
137. Hasler P., Zouali M. Immune receptor signaling, aging, and autoimmunity. Cell Immunol 2005, 233:102-108.
138. Krabbe K.S., Pedersen M., Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol 2004, 39:687-699.
139. Walston J., McBurnie M.A., Newman A., Tracy R.P., Kop W.J., Hirsch C.H., et al. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch Intern Med 2002, 162:2333-2341.
140. Goronzy J.J., Weyand C.M. Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation. Arthritis Res Ther 2003, 5:225-234.
141. Liuzzo G., Biasucci L.M., Trotta G., Brugaletta S., Pinnelli M., Digianuario G., et al. Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events. J Am Coll Cardiol 2007, 50:1450-1458.
142. Sammaritano L.R. Menopause in patients with autoimmune diseases. Autoimmun Rev 2011, doi:10.1016/j.autrev.2011.11.006 [Electronic publication ahead of print].
143. Costenbader K.H., Prescott J., Zee R.Y., De Vivo I. Immunosenescence and rheumatoid arthritis: does telomere shortening predict impending disease?. Autoimmun Rev 2011, 10:569-573.
144. Zhao M., Sun Y., Gao F., Wu X., Tang J., Yin H., et al. Epigenetics and SLE: RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells. J Autoimmun 2010, 35:58-69.
145. Costenbader K.H., Gay S., Riquelme M.E., Iaccarino L., Doria A. Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases?. Autoimmun Rev 2011, doi:10.1016/j.autrev.2011.10.022 [Electronic publication ahead of print].
146. Thamilarasan M., Koczan D., Hecker M., Paap B., Zettl U.K. MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis. Autoimmun Rev 2011, doi:10.1016/j.autrev.2011.05.009 [Electronic publication ahead of print].
147. Hodge D.R., Cho E., Copeland T.D., Guszczynski T., Yang E., Seth A.K., et al. IL-6 enhances the nuclear translocation of DNA cytosine-5-methyltransferase 1 (DNMT1) via phosphorylation of the nuclear localization sequence by the AKT kinase. Cancer Genomics Proteomics 2007, 4:387-398.
148. Pallis M., Robins A., Powell R. Quantitative analysis of lymphocyte CD11a using standardized flow cytometry. Scand J Immunol 1993, 38:559-564.
149. Takeda T., Hosokawa M., Takeshita S., Irino M., Higuchi K., Matsushita T., et al. A new murine model of accelerated senescence. Mech Ageing Dev 1981, 17:183-194.
150. Sorensen J.G., Kristensen T.N., Kristensen K.V., Loeschcke V. Sex specific effects of heat induced hormesis in Hsf-deficient Drosophila melanogaster. Exp Gerontol 2007, 42:1123-1129.
151. Kim S., Bi X., Czarny-Ratajczak M., Dai J., Welsh D.A., Myers L., et al. Telomere maintenance genes SIRT1 and XRCC6 impact age-related decline in telomere length but only SIRT1 is associated with human longevity. Biogerontology 2011, doi:10.1007/s10522-011-9360-5 [Electronic publication ahead of print].
152. Park S.H., Ozden O., Jiang H., Cha Y.I., Pennington J.D., Aykin-Burns N., et al. Sirt3, Mitochondrial ROS, Ageing, and Carcinogenesis. Int J Mol Sci 2011, 12:6226-6239. doi:10.3390/ijms12096226 [Electronic publication ahead of print].